Amylin - Topic profile

  Recs: 0 Is Exenatide Once a Week the magic bullet which delivers profitability and allows Amylin expand its R&D efforts ? Based on today's numbers, it's going to take a whole lot of Exenatide Once a Week sales in the near term to make it happen. Amylin's projected 2008 annual revenues after Lilly's share is about = $500 million Amylin projected 2008 net loss is ...

  Recs: 5 Wall Street Journal article on Amylin option trading with paragraph about ELN Calls trading The biotech company Elan Corp. also saw some action, with calls outnumbering puts nearly four to one. One large trader pursued a bullish call spread in January contracts, buying $17.50 calls and selling $22.50 calls. Currently priced at 75 cents, the ...

  Recs: 2 Google Alert for Amylin: Wedding bells at AMLN! [This oughta piss off the rednecks!!!] Wedding announcements NEWS     Published 08/21/2008 compiled by Cynthia Laird c.laird@ebar.com...

  Recs: 0 2nd most active trading day today 23,058,039 ever for Amylin since August 23, 2005 32,168,500 23-Aug-05 28.12 28.79 26.47 28.00 32,168,500 28.00 22-Aug-05 22.00 22.17...

  Recs: 0 Tuesday, Aug. 19 Headline: Eli Lilly Purchases Amylin Pharma for $42 representing a 50% premium over their closing price of $28 on 8/18

  Recs: 10 Motley Fool bullish on AMLN Anemic Amylin's Signs of Recovery By Brian Orelli July 22, 2008   Sales of Amylin Pharmaceuticals ' (Nasdaq: AMLN ) diabetes drug Byetta have slowed over the last few quarters, but the company seems to be turning things around. Can it continue that trend in the face of coming competition from Novo ...

  Recs: 3 I don't know which is more annoying Naked Shorts or Co3aii irresponsible posts ? The thing I find most annoying about Co3aii is his constant one sided views about Amylin, which is subjective and unsubstantiated. He tries to validate his opinions not by offering any kind of objective DD which he has performed on his own, but rather by discrediting and attacking ...

  Recs: 0 Report Headline: "Spotlight On Januvia Skin Reactions, But Not Likely To Boost Byetta Use" AMYLIN PHARMACEUTICALS INC EPS Estimated At -2.01   Jul 15, 2008 (Nelson's Broker Summaries via COMTEX) --   Company: AMYLIN PHARMACEUTICALS INC Report Headline: "Spotlight On Januvia Skin Reactions, But Not Likely To Boost Byetta Use" Report Date: July...

  Recs: 0 Huckman update on FBR dropping coverage of biopharmas et al.       Finally, an update to my recent post about the cost-cutting game of musical chairs being played in biopharma equities research . Late Wednesday I got 50 (yes, fifty) emails from FBR ( FBR ) individually announcing the firm is dropping coverage--not suspending, but dropping--...

  Recs: 8 Is Januvia and Janumet heading towards an FDA Black Box waring on their labels ? Pfizer, Merck And Lilly Partner Up To Get "Enlightened" Posted By: Mike Huckman Topics: Stock Market | Medicine | Pharmaceuticals Sectors: Insurance | Health Care Equipment and Services | Health Care | Pharmaceuticals Companies: ...

ok, thanks so much for the replies-- this is extremely helpful.

Judged: 3 3 2 Another Lilly drug over-promotion bites the dust Eli Lilly should consider is how Zyprexa is being avoided by doctors they aren't prescribing it for new patients at all anymore. Of course Lilly deserves to go to hell for LYING about Zyprexa side effects. HERE http://www.insideindianabusiness.com/newsitem... Connecticut Sues Lilly Over Zyprexa (this is a RICO...

It's very sad that some people died, but don't forget about the hundreds of thousands who have benefited. Theres no reason to think Byetta is a big scary dangerous drug, we just need to monitor patients more closely and tell them what the warning signs of pancreatitus are.

  Recs: 0 Re: Amylin and Lilly Set Date and Time for Conference Call Companies Will Discuss Recent FDA Advisory Regarding BYETTA Amylin and Lilly Set Date and Time for Conference Call Companies Will Discuss Recent FDA Advisory Regarding BYETTA SAN DIEGO, Aug. 25 /PRNewswire-FirstCall/ ...